Skip to main content

Table 2 Treatment characteristics of the enrolled patients

From: Genetic polymorphisms in the endothelial nitric oxide synthase gene correlate with overall survival in advanced non-small-cell lung cancer patients treated with platinum-based doublet chemotherapy

 

No. of patients

 

Stage IIIA

Stage IIIB

Stage IV

CBDCA + PAC + TRT

6

14

0

CBDCA + PAC

0

13

56

CBDCA + GEM

0

3

14

CDDP + GEM

0

0

2

  1. Abbreviations: TRT, thoracic radiotherapy
Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us